We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CSX Corp
CSX
$94.5B
| $60.9M | 0.15% |
2,352,204
+59,700
| +3% | +$1.47M |
|
152
Synchrony
SYF
$25.9B
| $60.9M | 0.15% |
2,325,242
+799,279
| +52% | +$19.4M |
|
153
Deere & Co
DE
$165B
| $60.5M | 0.15% |
272,759
+73,933
| +37% | +$14.3M |
|
154
XP
XP
$8.89B
| $59.7M | 0.15% |
1,432,960
+91,914
| +7% | +$4.2M |
|
|
MRSH
155
Marsh
MRSH
$91.3B
| $58.1M | 0.15% |
506,979
+11,600
| +2% | +$1.33M |
|
|
ARCH
156
DELISTED
Arch Resources, Inc.
ARCH
| $57.8M | 0.14% |
1,361,367
+161,197
| +13% | +$5.72M |
|
|
SAGE
157
DELISTED
Sage Therapeutics
SAGE
| $57.6M | 0.14% |
+942,000
| New | +$47.7M |
|
158
Regeneron Pharmaceuticals
REGN
$79.1B
| $57M | 0.14% |
101,736
-49,150
| -33% | -$29.8M |
|
159
Newmont
NEM
$110B
| $56.6M | 0.14% |
891,900
-40,000
| -4% | -$2.61M |
|
160
Autodesk
ADSK
$50.1B
| $56.3M | 0.14% |
243,689
-9,000
| -4% | -$2.14M |
|
|
INFO
161
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $56.2M | 0.14% |
715,957
+156,400
| +28% | +$12.5M |
|
162
Edwards Lifesciences
EW
$51.1B
| $55.6M | 0.14% |
696,666
-18,285
| -3% | -$1.43M |
|
|
CXO
163
DELISTED
CONCHO RESOURCES INC.
CXO
| $55.6M | 0.14% |
1,259,300
+184,900
| +17% | +$9.22M |
|
|
NBP
164
NovaBridge Biosciences American Depositary Shares
NBP
$191M
| $55.5M | 0.14% |
1,180,072
+62,755
| +6% | +$2.07M |
|
165
Citizens Financial Group
CFG
$31.2B
| $55.5M | 0.14% |
2,194,720
-1,003,519
| -31% | -$25.5M |
|
166
Estee Lauder
EL
$31.7B
| $55.5M | 0.14% |
254,084
-5,600
| -2% | -$1.15M |
|
|
SUM
167
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $55.3M | 0.14% |
3,401,051
-222,097
| -6% | -$3.56M |
|
168
Automatic Data Processing
ADP
$107B
| $54.6M | 0.14% |
391,476
+54,400
| +16% | +$7.62M |
|
|
LPRO
169
DELISTED
Open Lending Corp
LPRO
| $54.5M | 0.14% |
2,137,951
+585,077
| +38% | +$11.4M |
|
170
Timken Company
TKR
$9.16B
| $53.6M | 0.13% |
988,878
-1,663,701
| -63% | -$85.9M |
|
171
Legend Biotech
LEGN
$3.7B
| $53.3M | 0.13% |
1,727,267
+692,095
| +67% | +$23.3M |
|
172
Moody's
MCO
$83.7B
| $52.3M | 0.13% |
180,354
-6,721
| -4% | -$1.92M |
|
173
CF Industries
CF
$18.1B
| $52.2M | 0.13% |
1,699,243
-646,299
| -28% | -$20.6M |
|
174
Capital One
COF
$136B
| $52.2M | 0.13% |
726,159
-522,970
| -42% | -$35M |
|
175
OneMain Financial
OMF
$7.52B
| $50.9M | 0.13% |
1,629,469
-274,033
| -14% | -$7.8M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.